Home
About
Overview
Sharing Data
ORCID
Help
History (65)
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up.
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential.
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
See All 65 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer. J Neurol. 2019 12; 266(12):3163-3166.
View in:
PubMed
subject areas
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Carcinoma, Non-Small-Cell Lung
Female
Humans
Lung Neoplasms
Multiple Sclerosis
authors with profiles
Marina Chiara Garassino